Home › Neuroendocrine Carcinoma › Colorado › Denver
Neuroendocrine Carcinoma clinical trials in Denver, CO
3 studies for Neuroendocrine Carcinoma are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
RecruitingPhase 1/2
- Crinetics Study Site, Denver
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
RecruitingPhase 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
RecruitingPhase 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
Neuroendocrine Carcinoma trials in other cities
- Houston, TX6 studies
- New York City, NY6 studies
- Arlington, VA5 studies
- Dallas, TX4 studies
- Los Angeles, CA4 studies
- Washington, DC3 studies
- Seattle, WA3 studies
- Grand Rapids, MI3 studies
- Nashville, TN3 studies
- St. Louis, MO3 studies
- Atlanta, GA3 studies
- New Haven, CT3 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer28 studies
- Non-Small Cell Lung Cancer27 studies
- Multiple Myeloma26 studies
- Colorectal Cancer23 studies
- Cancer (all types)19 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Ovarian Cancer16 studies
- Endometrial Cancer16 studies
- Lung Cancer16 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.